Добірка наукової літератури з теми "Optimisation de hit en lead"
Оформте джерело за APA, MLA, Chicago, Harvard та іншими стилями
Ознайомтеся зі списками актуальних статей, книг, дисертацій, тез та інших наукових джерел на тему "Optimisation de hit en lead".
Біля кожної праці в переліку літератури доступна кнопка «Додати до бібліографії». Скористайтеся нею – і ми автоматично оформимо бібліографічне посилання на обрану працю в потрібному вам стилі цитування: APA, MLA, «Гарвард», «Чикаго», «Ванкувер» тощо.
Також ви можете завантажити повний текст наукової публікації у форматі «.pdf» та прочитати онлайн анотацію до роботи, якщо відповідні параметри наявні в метаданих.
Статті в журналах з теми "Optimisation de hit en lead"
Padalino, Gilda, Nelly El-Sakkary, Lawrence J. Liu, Chenxi Liu, Danielle S. G. Harte, Rachel E. Barnes, Edward Sayers, et al. "Anti-schistosomal activities of quinoxaline-containing compounds: From hit identification to lead optimisation." European Journal of Medicinal Chemistry 226 (December 2021): 113823. http://dx.doi.org/10.1016/j.ejmech.2021.113823.
Повний текст джерелаEl Bakali, Jamal, Lucie Maingot, Julie Dumont, Helene Host, Akila Hocine, Nicolas Cousaert, Sandrine Dassonneville, Florence Leroux, Benoit Deprez, and Rebecca Deprez-Poulain. "Novel selective inhibitors of neutral endopeptidase: discovery by screening and hit-to-lead optimisation." MedChemComm 3, no. 4 (2012): 469. http://dx.doi.org/10.1039/c2md00287f.
Повний текст джерелаBobrovs, Raitis, Jekaterina Bolsakova, Jhon Alexander Rodriguez Buitrago, Larisa Varaceva, Marija Skvorcova, Iveta Kanepe, Anastasija Rudnickiha, Emilio Parisini, and Aigars Jirgensons. "Structure-based identification of salicylic acid derivatives as malarial threonyl tRNA-synthetase inhibitors." PLOS ONE 19, no. 4 (April 1, 2024): e0296995. http://dx.doi.org/10.1371/journal.pone.0296995.
Повний текст джерелаMostarda, Serena, Tugçe Gür Maz, Alessandro Piccinno, Bruno Cerra, and Erden Banoglu. "Optimisation by Design of Experiment of Benzimidazol-2-One Synthesis under Flow Conditions." Molecules 24, no. 13 (July 3, 2019): 2447. http://dx.doi.org/10.3390/molecules24132447.
Повний текст джерелаOsborne, James, Stanislava Panova, Magdalini Rapti, Tatsuya Urushima, and Harren Jhoti. "Fragments: where are we now?" Biochemical Society Transactions 48, no. 1 (January 27, 2020): 271–80. http://dx.doi.org/10.1042/bst20190694.
Повний текст джерелаTaki, Aya C., Joseph J. Byrne, Tao Wang, Brad E. Sleebs, Nghi Nguyen, Ross S. Hall, Pasi K. Korhonen, et al. "High-Throughput Phenotypic Assay to Screen for Anthelmintic Activity on Haemonchus contortus." Pharmaceuticals 14, no. 7 (June 26, 2021): 616. http://dx.doi.org/10.3390/ph14070616.
Повний текст джерелаZaidi, Norburhanuddin Johari, Adib Afandi Abdullah, Choon Han Heh, Chun-Hung Lin, Rozana Othman, and Abdullah Al Hadi Ahmad Fuaad. "Hit-to-Lead Short Peptides against Dengue Type 2 Envelope Protein: Computational and Experimental Investigations." Molecules 27, no. 10 (May 18, 2022): 3233. http://dx.doi.org/10.3390/molecules27103233.
Повний текст джерелаKandil, Sahar B., Samuel R. Jones, Sonia Smith, Stephen E. Hiscox, and Andrew D. Westwell. "Structure-Based Virtual Screening, Synthesis and Biological Evaluation of Potential FAK-FAT Domain Inhibitors for Treatment of Metastatic Cancer." Molecules 25, no. 15 (July 31, 2020): 3488. http://dx.doi.org/10.3390/molecules25153488.
Повний текст джерелаScanlon, Martin. "Monash Fragment Platform." Impact 2018, no. 3 (June 15, 2018): 32–34. http://dx.doi.org/10.21820/23987073.2018.3.32.
Повний текст джерелаMager, Magnus. "Noise performance of the ALPIDE-based ALICE Inner Tracking System." Journal of Physics: Conference Series 2374, no. 1 (November 1, 2022): 012062. http://dx.doi.org/10.1088/1742-6596/2374/1/012062.
Повний текст джерелаДисертації з теми "Optimisation de hit en lead"
Quevedo, Camilo E. "Design and synthesis of Quinazolinone-based libraries for inhibitation of Kinase activity and hit-to-lead optimisation of Wnt pathway inhibitors." Thesis, Institute of Cancer Research (University Of London), 2008. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.510367.
Повний текст джерелаBorzakian, Sibyline. "Identification et développement chimique d'inducteurs de protéines immunorégulatrices (SLPI et IL-10) à visée thérapeutique." Electronic Thesis or Diss., université Paris-Saclay, 2024. http://www.theses.fr/2024UPASF012.
Повний текст джерелаThe work carried out during this thesis has been divided into three distincts parts, all relating to the developpement of compounds for therapeutic use. The first part of this manuscript is devoted to the identification of inducers of Secretory Leucocyte Protease Inhibitor (SLPI), a protein mainly produced by immune and epithelial cells, with numerous promising biological properties. A phenotypic screening was conducted using two academic chemical libraries, leading to the identification of 5 hits able of inducing SLPI production by B cells. This work paved the way for potential therapeutic applications of these compounds, particularly in the development of antibiotic or anti-inflammatory treatments. The second part of this manuscript is dedicated to identifying a pharmacophore for inducers of Interleukin-10 (IL-10), a cytokine produced by immune cells, whose main role is the regulation of immunity. Prior to this thesis, a phenotypic screening was conducted to identifiy inducers of IL-10 production by B cells for use in cell therapy to reduce symptoms of multiple sclerosis. This thesis work involved hit-to-lead optimization of the most promising compound to identify a pharmacophore for IL-10 inducers through the establishment of robust structure-activity relationships. During this phase, 240 analogs were synthetized. Finally, the third part of this manuscript focuses on the development of a photochemical synthesis methology for accessing original heterocylic compounds. This methology, requiring neither heating nor metallic catalysts, aligns with the development of greener chemistry
Samson, Samantha. "Profilage in silico de la protéine multifonctionnelle Mfd, une cible thérapeutique innovante dans la lutte contre l'antibiorésistance bactérienne." Electronic Thesis or Diss., université Paris-Saclay, 2024. http://www.theses.fr/2024UPASL125.
Повний текст джерелаIn an alarming context of antibiotic resistance, the search for new antimicrobials is an urgent health issue. We had identified the bacterial protein Mutation Frequency Decline (Mfd) as an innovative target for the development of new drugs. A high throughput in silico screening was initially performed in order to select molecules specifically binding to the active site of the target and inhibiting its activity, thereby preventing bacterial resistance to host immune stress. The identified hits were shown to be efficient in vitro and efficient and non-toxic in vivo, in an insect model of infection on at least two bacterial pathogens. These preliminary data have constituted a proof of concept of the innovative potential of these hits and were also the basis of this thesis.The main objective of this work was the identification of the critical molecular interaction found between those hits and the active site of Mfd in E. coli and also enlarged to the priority pathogens of the ESKAPE group. As a result, an optimal inhibitor scaffold was determined and its derivatives are currently tested in vitro and in vivo as potential antimicrobial agents. In parallel, the sequence and structure analysis of Mfd, from environmental and clinical strains, showcase the basic features of a molecular correlation between Mfd sequence and virulence phenotype. The in vitro confirmation is currently being evaluated. Finally, my goal reposition this motor function of Mfd into a larger conformational and functional remodeling of Mfd in order to get a better understanding of this target and its role in the Nucleotide Excision Repair. Using molecular dynamics simulation on distinguished linkers that connect the main functional modules of Mfd, the investigation of their intrinsic flexibility and resilience to recapitulate the extensive remodeling of Mfd conformations within its functional cycle that has been previously described by cryo-EM. This aims to document to which extent the linkers that connect this multi-module protein are more than "linkers" and harbor, in their sequence and length, internal properties to adopt discrete states that guarantee disorder-to-coil transition to assure the functional machinery of Mfd
Papadatos, George. "Data mining for lead optimisation." Thesis, University of Sheffield, 2011. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.556989.
Повний текст джерелаNeiström, Linda. "Characterisation of Used Lead-Acid Batteries for Feed Optimisation in Secondary Lead Production." Thesis, Luleå tekniska universitet, Institutionen för samhällsbyggnad och naturresurser, 2018. http://urn.kb.se/resolve?urn=urn:nbn:se:ltu:diva-70740.
Повний текст джерелаYglesias, Tatiana. "Application of process analysis and optimization tools in hit-to-lead and lead optimization phases of drug discovery at EPP, NIBR." Thesis, Massachusetts Institute of Technology, 2010. http://hdl.handle.net/1721.1/59882.
Повний текст джерелаCataloged from PDF version of thesis.
Includes bibliographical references (p. 82-84).
Given that research is based on innovation, it has been believed that its activities can only be optimized with equipment upgrade, increment in personnel scientific knowledge, development of new analytical software and/or changing the areas of study. After realizing the limited results achieved with these approaches, lab representatives started to notice the opportunity of introducing process optimization tools, such as Lean and Six Sigma, which showed success in manufacturing environments,. This project analyzes the interrelation between process and results, providing a clear explanation of cause and effect conditions, and a concise list of areas for improvement. Specifically, the document defines a measurement system using process maps and key performance indicators (KPIs). With this, the document describes the current state through historic trends, provides a complete data and root cause analysis for current state description, and provides a process capability study for the available indicators. Implementation of the steps mentioned above show how focus in lab turnaround times have been deviating attention from more impactful improvements, which can greatly affect overall drug discovery duration. Also, the analysis identifies that constant technology changes caused constant adaptation of process procedures, which generated non-value added activities. These non-value added activities today occupy about 50% of a lab associate's time. Lastly, historic data evaluation shows that root cause statistical analysis is limited by the presence of a combination of special and common cause variations. Some of the project recommendations include: incorporation of chemist's knowledge about compound potency, integration of equipment and software information, change in booking system, incorporation of assay and plate criteria, definition of standard procedures for specific activities, and integration of assay development and data submission tools. Overall, these changes can lead to a 50% reduction in the profiling times greater than 60 days, decrease of 62% and 60% in Compound Manager (CM) and Compound Profiler (CP) non-value added times respectively, 30% decrease in CM and CP total duration per assay plate, and increase in profiling time stability and predictability. Despite the fact that timing and scale of available resources will impact the realized benefits, the proposed framework gives EPP the opportunity to assess the improvements by their effect and alignment with goals.
by Tatiana Yglesias.
M.B.A.
S.M.
Voitovich, Iuliia. "Les inhibiteurs d'interaction protéine-protéine, une stratégie innovante en cancérologie." Thesis, Aix-Marseille, 2018. http://www.theses.fr/2018AIXM0701.
Повний текст джерелаBET-proteins, acting as epigenetic readers, play an essential role in cancer development. To date, numerous potent inhibitors disrupting BET functions have been discovered, including several of them that are undergoing clinical trials for the treatment of different types of cancer. The common drawback limiting their use in clinical practice is an inability to distinguish between BET-members that may cause side effects and resistances. The selective targeting of individual BET and the discrimination between BD1 and BD2 present an opportunity to achieve more selective transcriptional effect. A midthroughput screening of previously designed chemical library allowed identification of two molecules with unique profiles of selectivity that have never been observed. An undertaken structure-based program revealed a minimum scaffolds necessary for binding. Taking together with resolved X-Ray structures it allowed the development of more potent and selective BET inhibitors by DOTS (diversity oriented target focused synthesis) strategy, combining virtual screening and diversity oriented library design. This optimization led to a potent inhibitor with up to 100-fold improvement of affinity to the target and up to 300-fold selectivity toward BD1. Dose-response downregulation of c-Myc levels in low micromolar range in cell assays allowed the validation of the identified molecule as a chemical probe. Further comprehensive in vitro and in vivo evaluations of this compound will enable elucidating the biological role of each bromodomain and a validation of the interest toward the development of selective inhibitors in clinic
Mariani, Alessandro. "Optimisation of valve regulated lead acid battery design for high power applications." Thesis, University of South Wales, 2017. https://pure.southwales.ac.uk/en/studentthesis/optimisation-of-valve-regulated-lead-acid-battery-design-for-high-power-applications(f8316110-ebc1-4f0b-9e1b-4a66d7e50564).html.
Повний текст джерелаFilippi, Andrea <1990>. "An application of Genetic Algorithms for the Lead Molecule Optimisation. (Titolo provvisorio)." Master's Degree Thesis, Università Ca' Foscari Venezia, 2016. http://hdl.handle.net/10579/9366.
Повний текст джерелаMoffat, Kirstin. "Development of computational methods for 3D similarity and structure-based design techniques in lead optimisation." Thesis, University of Sheffield, 2006. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.434521.
Повний текст джерелаКниги з теми "Optimisation de hit en lead"
Faller, Bernard, and Laszlo Urban, eds. Hit and Lead Profiling. Wiley, 2009. http://dx.doi.org/10.1002/9783527627448.
Повний текст джерелаRamaswamy, Vijayan, and Vasanthanathan Poongavanam. Computational Drug Discovery: From Hit to Lead Optimization. Wiley & Sons, Limited, John, 2023.
Знайти повний текст джерелаOptimisation of Corrosion Control for Lead in Drinking Water Using Computational Modelling Techniques. IWA Publishing, 2013.
Знайти повний текст джерелаHayes, Colin, Croft, T N. Optimisation of Corrosion Control for Lead in Drinking Water Using Computational Modelling Techniques. IWA Publishing, 2012.
Знайти повний текст джерелаUrban, Laszlo, Gerd Folkers, Raimund Mannhold, Hugo Kubinyi, and Bernard Faller. Hit and Lead Profiling: Identification and Optimization of Drug-Like Molecules. Wiley & Sons, Limited, John, 2010.
Знайти повний текст джерелаUrban, Laszlo, Gerd Folkers, Raimund Mannhold, Hugo Kubinyi, and Bernard Faller. Hit and Lead Profiling: Identification and Optimization of Drug-Like Molecules. Wiley & Sons, Limited, John, 2010.
Знайти повний текст джерелаUrban, Laszlo, Gerd Folkers, Raimund Mannhold, Hugo Kubinyi, and Bernard Faller. Hit and Lead Profiling: Identification and Optimization of Drug-Like Molecules. Wiley & Sons, Limited, John, 2010.
Знайти повний текст джерелаHit and lead profiling: Identification and optimization of drug-like molecules. Weinheim: Wiley-VCH, 2009.
Знайти повний текст джерелаUrban, Laszlo, Gerd Folkers, Raimund Mannhold, Hugo Kubinyi, and Bernard Faller. Hit and Lead Profiling: Identification and Optimization of Drug-Like Molecules. Wiley & Sons, Incorporated, John, 2009.
Знайти повний текст джерелаNow Lead the Change: Repurpose Your Career, Future-Proof Your Organization, and Regenerate Our Crisis-Hit World by Mastering Transformational Leadership. Switch On Books, 2020.
Знайти повний текст джерелаЧастини книг з теми "Optimisation de hit en lead"
Mazanetz, Michael, Richard Law, and Mark Whittaker. "Hit and Lead Identification from Fragments." In De novo Molecular Design, 143–200. Weinheim, Germany: Wiley-VCH Verlag GmbH & Co. KGaA, 2013. http://dx.doi.org/10.1002/9783527677016.ch6.
Повний текст джерелаDunlap, Norma, and Donna M. Huryn. "Drug discovery: hit and lead identification." In Medicinal Chemistry, 19–50. New York, NY : Garland Science, Taylor & Francis Group, LLC, [2018]: Garland Science, 2018. http://dx.doi.org/10.1201/9781315100470-2.
Повний текст джерелаBraggio, Simone, Mauro Corsi, Aldo Feriani, Stefano Fontana, Luciana Marocchio, and Caterina Virginio. "CHAPTER 15. Discovery Toxicology In Lead Optimisation." In The Handbook of Medicinal Chemistry, 364–412. Cambridge: Royal Society of Chemistry, 2015. http://dx.doi.org/10.1039/9781782621836-00364.
Повний текст джерелаCregan, Vincent, and William T. Lee. "Optimisation of a Lead Sulphate Settling Process." In Trends in Mathematics, 1–6. Cham: Springer International Publishing, 2018. http://dx.doi.org/10.1007/978-3-030-01153-6_1.
Повний текст джерелаConnolly, Stephen, and Simon E. Ward. "CHAPTER 21. Lead Optimisation: What You Should Know!" In The Handbook of Medicinal Chemistry, 529–65. Cambridge: Royal Society of Chemistry, 2015. http://dx.doi.org/10.1039/9781782621836-00529.
Повний текст джерелаKapoulitsas, P., M. Giunti, R. Hampson, A. Cranley, S. Gray, B. Kretschmer, R. Knight, and J. Clark. "Commissioning and Optimisation of the New Lead and Silver Refinery at the Pasminco Port Pirie Smelter." In Lead-Zinc 2000, 187–202. Hoboken, NJ, USA: John Wiley & Sons, Inc., 2013. http://dx.doi.org/10.1002/9781118805558.ch10.
Повний текст джерелаSewing, A., and D. Cawkill. "High-Throughput Lead Finding and Optimisation for GPCR Targets." In Ernst Schering Foundation Symposium Proceedings, 249–66. Berlin, Heidelberg: Springer Berlin Heidelberg, 2007. http://dx.doi.org/10.1007/2789_2006_012.
Повний текст джерелаPignol, Jean-Philippe, Philippe Paquis, Roland Sabattier, Arlene Lennox, Thomas Kroc, Dan Jones, Jakobus Slabbert, Cheikh M. B. Diop, Gilbert Blondiau, and Noël Breteau. "BNCEFN Optimisation with Lead Blocks Collimation and Graphite Embedding." In Frontiers in Neutron Capture Therapy, 741–46. Boston, MA: Springer US, 2001. http://dx.doi.org/10.1007/978-1-4615-1285-1_107.
Повний текст джерелаHeifetz, Alexander, Michelle Southey, Inaki Morao, Andrea Townsend-Nicholson, and Mike J. Bodkin. "Computational Methods Used in Hit-to-Lead and Lead Optimization Stages of Structure-Based Drug Discovery." In Methods in Molecular Biology, 375–94. New York, NY: Springer New York, 2017. http://dx.doi.org/10.1007/978-1-4939-7465-8_19.
Повний текст джерелаLipinski, Christopher A. "Overview of Hit to Lead: The Medicinal Chemist's Role from HTS Retest to Lead Optimization Hand Off." In Topics in Medicinal Chemistry, 1–24. Berlin, Heidelberg: Springer Berlin Heidelberg, 2009. http://dx.doi.org/10.1007/7355_2009_4.
Повний текст джерелаТези доповідей конференцій з теми "Optimisation de hit en lead"
Aimetta, A., N. Abrate, M. Massone, and S. Dulla. "Advancements in the Genetic-Driven Optimisation of the Few-Group Structures for Lead Fast Reactors Analysis." In International Conference on Physics of Reactors (PHYSOR 2024), 1703–12. Illinois: American Nuclear Society, 2024. http://dx.doi.org/10.13182/physor24-43878.
Повний текст джерелаMo¨ller, Bjo¨rn Fredriksson, Mitsuru Obana, Mohsen Assadi, and Athanasios Mitakakis. "Optimisation of HAT-Cycles – With and Without CO2 Capture." In ASME Turbo Expo 2004: Power for Land, Sea, and Air. ASMEDC, 2004. http://dx.doi.org/10.1115/gt2004-53734.
Повний текст джерелаPietrikova, Alena, L'ubomir Livovsky, Jan Urbancik, and Radoslav Bucko. "Optimisation of Lead Free Solders Reflow Profile." In 2006 29th International Spring Seminar on Electronics Technology. IEEE, 2006. http://dx.doi.org/10.1109/isse.2006.365149.
Повний текст джерела"Searching for bioactive drug lead compounds from natural humic substances." In Seventh International Conference on Humic Innovative Technologies "Humic substances and technologies for resilience" (HIT – 2022). NP CBR "Humus Sapiens", 2022. http://dx.doi.org/10.36291/hit.2022.071.
Повний текст джерелаAlexander, Brian G., Roberta Pireddu, Nan N. Sun, Huidong Yu, Kara D. Forinash, Matthew P. Martin, Ernst Schonbrunn, Wayne C. Guida, Said M. Sebti, and Nicholas J. Lawrence. "Abstract 3243: Discovery of novel Rho kinase inhibitors: Hit generation and lead optimization." In Proceedings: AACR 102nd Annual Meeting 2011‐‐ Apr 2‐6, 2011; Orlando, FL. American Association for Cancer Research, 2011. http://dx.doi.org/10.1158/1538-7445.am2011-3243.
Повний текст джерелаSeufitelli, Danilo Boechat, and Mirella M. Moro. "Understanding Musical Success Beyond Hit Songs: Characterization and Analyses of Musical Careers." In Anais Estendidos do Simpósio Brasileiro de Sistemas Multimídia e Web, 23–24. Sociedade Brasileira de Computação - SBC, 2024. http://dx.doi.org/10.5753/webmedia_estendido.2024.244326.
Повний текст джерелаPireddu, Roberta, Harshani R. Lawrence, Mathew P. Martin, Stephane Betzi, Richard Yip, Hua Yang, Nan N. Sun, et al. "Abstract 3253: Novel oxindole inhibitors of Aurora A kinase: Structure based hit-to-lead approach." In Proceedings: AACR 102nd Annual Meeting 2011‐‐ Apr 2‐6, 2011; Orlando, FL. American Association for Cancer Research, 2011. http://dx.doi.org/10.1158/1538-7445.am2011-3253.
Повний текст джерелаKavicka, Frantisek, Josef Stetina, Karel Stransky, Jana Dobrovska, Bohumil Sekanina, and Jaromir Heger. "A Numerical Model of Solidification of a Massive Casting From Malleable Cast-Iron." In ASME 2004 Heat Transfer/Fluids Engineering Summer Conference. ASMEDC, 2004. http://dx.doi.org/10.1115/ht-fed2004-56043.
Повний текст джерелаScherff, Maximilian L. D., Stefan Schwertheim, Yue Ma, Thomas Mueller, and Wolfgang R. Fahrner. "10 × 10 cm2 Hit Solar Cells Contacted with Lead-Free Electrical Conductive Adhesives to Solar Cell Interconnectors." In Conference Record of the 2006 IEEE 4th World Conference on Photovoltaic Energy Conversion. IEEE, 2006. http://dx.doi.org/10.1109/wcpec.2006.279709.
Повний текст джерелаBaines, Olivia, Rina Sha, Christopher O’Shea, and Davor Pavlovic. "BS10 Cardiac pacing location- optimisation of optical mapping protocols and pacemaker lead position." In British Cardiovascular Society Annual Conference, ‘Back to the patient’, 3–5 June 2024. BMJ Publishing Group Ltd and British Cardiovascular Society, 2024. http://dx.doi.org/10.1136/heartjnl-2024-bcs.236.
Повний текст джерелаЗвіти організацій з теми "Optimisation de hit en lead"
Chhoeung, Norinmony, Sesokunthideth Chrea, and Nghia Nguyen. Cambodia’s Cash Transfer Program during COVID-19. Asian Development Bank Institute, December 2022. http://dx.doi.org/10.56506/rrmz8095.
Повний текст джерелаAmzallag, Robert. The return of inflation: a banker’s perspective. CIRANO, May 2022. http://dx.doi.org/10.54932/egsn1582.
Повний текст джерелаOr, Etti, David Galbraith, and Anne Fennell. Exploring mechanisms involved in grape bud dormancy: Large-scale analysis of expression reprogramming following controlled dormancy induction and dormancy release. United States Department of Agriculture, December 2002. http://dx.doi.org/10.32747/2002.7587232.bard.
Повний текст джерела